These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5136045)

  • 1. [Contribution on so-called auricular disease].
    Johanovská K; Kozená J
    Sb Lek; 1971 Dec; 73(11):289-307. PubMed ID: 5136045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conversion of atrial fibrillation and flutter by a combination of anti-arrhythmic drugs].
    Pidrman V; Hamet A
    Vnitr Lek; 1972 Sep; 18(9):845-8. PubMed ID: 4403993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the beta receptor affecting substance Iproveratril on heart rate and arrhythmia].
    Hofmann H
    Z Gesamte Inn Med; 1969 Sep; 24(17):561-7. PubMed ID: 4393852
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paroxysmal atrial fibrillation, atrial flutter, and atrial flutter-fibrillation].
    Sumiyoshi M; Nakata Y
    Ryoikibetsu Shokogun Shirizu; 1996; (12):440-3. PubMed ID: 9047505
    [No Abstract]   [Full Text] [Related]  

  • 7. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Programmed esophageal stimulation of the atrium and the long-term effects of anti-arrhythmia therapy of atrial fibrillation and flutter].
    Novotný E; Uhrová V; Suda J
    Vnitr Lek; 1995 Sep; 41(9):586-9. PubMed ID: 7483347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic cardioversion for atrial fibrillation and flutter.
    Cayley WE
    Am Fam Physician; 2005 Dec; 72(11):2217-9. PubMed ID: 16342843
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new anti-arrhythmic agent: a prolonged-action derivative of quinidine].
    Warembourg H; Ducloux G
    Lille Med; 1971 Jan; 16():Suppl 1:234-7. PubMed ID: 5162045
    [No Abstract]   [Full Text] [Related]  

  • 12. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic possibilities in paroxysmal tachycardia with the use of the synthetic antihistaminic, 2-phenylbenzylaminomethylimidazoline].
    Nicita-Mauro V
    Folia Cardiol; 1967; 26(1):26-36. PubMed ID: 4383306
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide.
    Katcher MS; Estes NA
    Pharmacotherapy; 1997; 17(1):177-80. PubMed ID: 9017781
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic pharmacologic therapy for atrial fibrillation and flutter.
    Khouzam S; Kirk M
    Med Health R I; 2004 Apr; 87(4):104-7. PubMed ID: 15168635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of atrial fibrillation and flutter].
    Fazekas T
    Orv Hetil; 2003 Aug; 144(34):1687-9. PubMed ID: 14528843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 19. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
    Cosío FG; Delpón E
    Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.